Zelluna appoints new CFO
“Interest from the scientific and investor communities in Zelluna’s TCRs has increased substantially throughout 2018. As a result, Zelluna selected a CFO with the appropriate expertise to match the therapeutic potential of the company,” said Miguel Forte, CEO, Zelluna. “The strong financial experience of Geir Christian in successfully leading financing rounds and managing finances for biopharma companies is very relevant to secure future investment and increase operational capabilities as the Zelluna approaches the clinic.”
Geir Christian Melen brings to Zelluna extensive financial and management experience in the biotech industry, gained as CEO of Ostomycure and Clavis Pharma, as well as the CFO of Algeta and Photocure. This rounded experience includes financing, strategy and corporate development. He successfully guided both Algeta and Photocure through IPOs, and has led a variety of companies through fundraising rounds.